Figure 1
Figure 1. Mechanism of thrombin-catalyzed FV activation. Schematic representation of the human factor V activation pathway. Cleavage of the a2-B domain linker after Arg709 is followed by processing at the Arg1018-Thr1019 site, liberating the so-called fragment E (Ser710-Arg1018). Finally, slower proteolysis of the Arg1545-Ser1546 peptide bond releases fragment C1 (Thr1019-Arg1545), and generates a fully functional cofactor.48,49 Activated protein C (APC) cleavages at Arg306-Asn307, Arg506-Gly507, and Arg679-Lys680 that inactivate FVa are also indicated with arrowheads.

Mechanism of thrombin-catalyzed FV activation. Schematic representation of the human factor V activation pathway. Cleavage of the a2-B domain linker after Arg709 is followed by processing at the Arg1018-Thr1019 site, liberating the so-called fragment E (Ser710-Arg1018). Finally, slower proteolysis of the Arg1545-Ser1546 peptide bond releases fragment C1 (Thr1019-Arg1545), and generates a fully functional cofactor.48,49  Activated protein C (APC) cleavages at Arg306-Asn307, Arg506-Gly507, and Arg679-Lys680 that inactivate FVa are also indicated with arrowheads.

Close Modal

or Create an Account

Close Modal
Close Modal